BACKGROUND: Mitochondrial dysfunction is one of the most characteristic properties of the cancer cell. However, it is not known whether oxidative energy metabolism has already become altered in conditions of atrophic gastritis, a precancerous state of gastric disease. The purpose of our study was to comparatively characterize oxidative phosphorylation (OXPHOS) in the atrophic and nonatrophic gastric corpus mucosa. METHODS: Mucosal biopsies were taken from 12 patients with corpus dominant atrophic gastritis and from 12 patients with nonatrophic mucosa (controls). One part of the tissue samples was permeabilized with saponin for analysis of the function of the respiratory chain using high-resolution respirometry, and another part was used for histopathological examination. The serum level of pepsinogen I (S-PGI) was determined with a specific enzyme immunoassay (EIA). RESULTS: Compared to the control group, the maximal capacity of OXPHOS in the atrophy group was almost twofold lower, the respiratory chain complex I-dependent respiration, normalized to complex II-dependent respiration, was reduced, and respiratory control by ADP in the presence of succinate was increased in the atrophic corpus mucosa. In the whole cohort of the patients studied, serum S-PGI level correlated positively with complex I-dependent respiration or complex I-dependent to complex II-dependent respiration ratio. CONCLUSIONS: Corpus dominant atrophic gastritis is characterized by decreased respiratory capacity and relative deficiency of the respiratory complex I of mitochondria in the mucosa, the latter defect probably limiting mitochondrial ATP production and energetic support of the secretory function of the zymogenic mucosal cells.
BACKGROUND:Mitochondrial dysfunction is one of the most characteristic properties of the cancer cell. However, it is not known whether oxidative energy metabolism has already become altered in conditions of atrophic gastritis, a precancerous state of gastric disease. The purpose of our study was to comparatively characterize oxidative phosphorylation (OXPHOS) in the atrophic and nonatrophic gastric corpus mucosa. METHODS: Mucosal biopsies were taken from 12 patients with corpus dominant atrophic gastritis and from 12 patients with nonatrophic mucosa (controls). One part of the tissue samples was permeabilized with saponin for analysis of the function of the respiratory chain using high-resolution respirometry, and another part was used for histopathological examination. The serum level of pepsinogen I (S-PGI) was determined with a specific enzyme immunoassay (EIA). RESULTS: Compared to the control group, the maximal capacity of OXPHOS in the atrophy group was almost twofold lower, the respiratory chain complex I-dependent respiration, normalized to complex II-dependent respiration, was reduced, and respiratory control by ADP in the presence of succinate was increased in the atrophic corpus mucosa. In the whole cohort of the patients studied, serum S-PGI level correlated positively with complex I-dependent respiration or complex I-dependent to complex II-dependent respiration ratio. CONCLUSIONS:Corpus dominant atrophic gastritis is characterized by decreased respiratory capacity and relative deficiency of the respiratory complex I of mitochondria in the mucosa, the latter defect probably limiting mitochondrial ATP production and energetic support of the secretory function of the zymogenic mucosal cells.
Authors: M Kimura; S Goto; A Wada; K Yahiro; T Niidome; T Hatakeyama; H Aoyagi; T Hirayama; T Kondo Journal: Microb Pathog Date: 1999-01 Impact factor: 3.738
Authors: H I Maaroos; T Vorobjova; P Sipponen; R Tammur; R Uibo; T Wadström; R Keevallik; K Villako Journal: Scand J Gastroenterol Date: 1999-09 Impact factor: 2.423
Authors: A P Gimenez-Roqueplo; J Favier; P Rustin; J J Mourad; P F Plouin; P Corvol; A Rötig; X Jeunemaitre Journal: Am J Hum Genet Date: 2001-10-16 Impact factor: 11.025
Authors: H Väänänen; M Vauhkonen; T Helske; I Kääriäinen; M Rasmussen; H Tunturi-Hihnala; J Koskenpato; M Sotka; M Turunen; R Sandström; M Ristikankare; A Jussila; P Sipponen Journal: Eur J Gastroenterol Hepatol Date: 2003-08 Impact factor: 2.566
Authors: Frank Norbert Gellerich; Marcus Deschauer; Ying Chen; Tobias Müller; Stephan Neudecker; Stephan Zierz Journal: Biochim Biophys Acta Date: 2002-10-03
Authors: R Krolow; C Noschang; S N Weis; L F Pettenuzzo; A P Huffell; D M Arcego; M Marcolin; C S Mota; J Kolling; E B S Scherer; A T S Wyse; C Dalmaz Journal: Neurochem Res Date: 2012-02-11 Impact factor: 3.996
Authors: Karla G Sifroni; Carlos R Damiani; Cristhopher Stoffel; Mariane R Cardoso; Gabriela K Ferreira; Isabela C Jeremias; Gislaine T Rezin; Giselli Scaini; Patricia F Schuck; Felipe Dal-Pizzol; Emilio L Streck Journal: Mol Cell Biochem Date: 2010-05-04 Impact factor: 3.396
Authors: Jordana P Panatto; Isabela C Jeremias; Gabriela K Ferreira; Andrea C Ramos; Natalia Rochi; Cinara L Gonçalves; Juliana F Daufenbach; Gabriela C Jeremias; Milena Carvalho-Silva; Gislaine T Rezin; Giselli Scaini; Emilio L Streck Journal: Mol Cell Biochem Date: 2011-01-04 Impact factor: 3.396
Authors: Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Mateus Grings; Bruna Zanotto; Daniella M Coelho; Carmen R Vargas; Guilhian Leipnitz; Angela T S Wyse Journal: Mol Neurobiol Date: 2016-11-14 Impact factor: 5.590
Authors: Ali S Alfazari; Bayan Al-Dabbagh; Wafa Al-Dhaheri; Mazen S Taha; Ahmad A Chebli; Eva M Fontagnier; Zaher Koutoubi; Jose Kochiyi; Sherif M Karam; Abdul-Kader Souid Journal: World J Gastroenterol Date: 2015-01-14 Impact factor: 5.742
Authors: Ana O Fagundes; Giselli Scaini; Patricia M Santos; Monique U Sachet; Nayara M Bernhardt; Gislaine T Rezin; Samira S Valvassori; Patrícia F Schuck; João Quevedo; Emilio L Streck Journal: Neurochem Res Date: 2009-09-24 Impact factor: 3.996
Authors: Samira D T De Prá; Gabriela K Ferreira; Milena Carvalho-Silva; Júlia S Vieira; Giselli Scaini; Daniela D Leffa; Gabriela E Fagundes; Bruno N Bristot; Gabriela D Borges; Gustavo C Ferreira; Patrícia F Schuck; Vanessa M Andrade; Emilio L Streck Journal: Neurochem Res Date: 2013-12-03 Impact factor: 3.996